News Article

VLP Receives Additional Rounds of Funding from Major Vaccine Company
Date: Nov 30, 2011
Source: ( click here to go to the source)

Featured firm in this article: VLP Biotech Inc of San Diego, CA

In light of progress made with the initial contract for $100,000 awarded in December, 2009, VLP has received two more rounds of funding: $250,000 in March, 2011, and $500,000 in November, 2011. This funding will be used to further improve and optimize the vaccine candidate developed under the initial agreement. To date there is no prophylactic vaccine for the targeted pathogen which is the leading worldwide agent of serious pediatric respiratory tract disease.